RACHEL KOPPENOL: Open Payments
NPI 1972191575 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,379 in 30 payments from 7 companies in 2025. Trend: 2023 $1,044 · 2024 $555 · 2025 $1,379
Food & beverage: $1,277Education: $101
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $348 |
| Medtronic, Inc. | 2 | $289 |
| GlaxoSmithKline, LLC. | 10 | $272 |
| Regeneron Healthcare Solutions, Inc. | 7 | $269 |
| Stryker Corporation | 1 | $153 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
Products named: DUPIXENT, NUCALA, SCOPIS ENT, LIGASURE, STEALTHSTATION S8 PLATFORM, XOLAIR, NEFFY.
Industry payments across CA — which companies pay providers there.
